Molecular Docking and Pharmacophore-Based Virtual Screening of Novel Inhibitors for HCV NS5B RNA-Dependent RNA Polymerase Enzyme from Crude Sesame Essential Oil.

Molecular Docking and Pharmacophore-Based Virtual Screening of Novel Inhibitors for HCV NS5B RNA-Dependent RNA Polymerase Enzyme from Crude Sesame Essential Oil.

Lukeman A.J Shittu 1, 2*, Abiodun M. Jinadu 2, Remilekun K. Shittu 3, Solomon A. Shittu2.

1.Department of Anatomical Sciences, University of Abuja, Gwagwalada, Abuja, Nigeria.
2.Research and Development Department, Jireh Laboratories International LLC, P. O. Box 1813, Alief Texas, 77411, USA.
3.Department of Microbiology, Jireh International Laboratory, P. O. Box 882, Gwagwalada, Abuja, Nigeria.

American Journal of Biotechnology and Bioinformatics

Concern has been expressed worldwide about the rising prevalence of HCV induced acute hepatitis and chronic liver diseases with associated cirrhosis and liver cancers. However, the available synthetic drugs are ineffective for all the HCV genotypes especially in genotype-1 patients with about 40% viral response rates and numerous side effects. Besides, the availability of veritable bioinformatics tools which includes molecular docking and virtual screening studies have shown that computational generated models nowadays assists in modern drug design and development of novel and more potent inhibitors through the understanding of protein (receptors) -ligand (drugs) interaction mechanisms. Non-structural proteins especially the 5B (NS5B) is an RNA-dependent RNA polymerase implicated in the synthesis and replication of the HCV RNA; and has been a potential target for its inhibitory activities. Due to the paucity of knowledge, we aimed to determine the differential inhibitory activity of essential oils present in the crude Sesame leaves extracts on HCV-NS5B RNA dependent RNA polymerase. Using in-silico studies- a Microsoft pharmacophore-based virtual screening and molecular docking tools on the iGEMDOCK vs 2.0 software was used to dock the essential oil ligands on the generated HCV NS5B (PDB ID: 4EO6) RNA-dependent RNA polymerase protein. GC-MS of the leaves confirmed carboxylic acids and phenolic groups in the essential oils especially some potent antioxidants like alpha-linolenic acid, linoleic acid, oleic acid, etc. Moreover, Alpha-Linolenic acid/ALA (-102.2/-103.4 kcal/mol) and Linoleic acid/LA (-94.8/-109.8 kcal/mol) showed higher inhibitory impacts among the six top different docked ligands, selected based on their high differential binding affinity and pharmacological interaction energy profiles against HCV NS5B RNA polymerase activities, by forming more H-bond interactions than the NS5B co-crystallized ligand. ADMET showed that ALA is well tolerated without any apparent toxicity in the body. Hence, ALA having the highest inhibitory impacts against the HCV NS5B goes to confirm the beneficial impacts of carboxylic acids from Sesame plant in maintaining liver cellular integrity and as a natural inhibitor of HCV NS5B RNA dependent RNA Polymerase enzyme activities.

Keywords: Sesame Leaves, GCMS, Molecular Docking, Virtual Screening, In-Silico studies, HCV NS5B RNA Polymerase, Essential Oils

Free Full-text PDF

How to cite this article:
Lukeman A.J Shittu, Abiodun M Jinadu, Remilekun K. Shittu, Solomon A. Molecular Docking and Pharmacophore-Based Virtual Screening of Novel Inhibitors for HCV NS5B RNA-Dependent RNA Polymerase Enzyme from Crude Sesame Essential Oil. American Journal of Biotechnology and Bioinformatics, 2018; xx:xx (Online First Publication)


1. Zhang S, Computer-aided drug discovery and development. Methods Mol Biol, 2011; 716: 23-38.
2. Cotran R.S, Kumar V, Fausto N, Nelso F, Robbins S. L, Abbas A.K, Robbins and Cotran pathologic basis of disease (7th ed.). St. Louis, MO: Elsevier Saunders, 2005; p. 878. ISBN 0-7216-0187-1.
3. Alter M.J, Mast E.E, Moyer L.A, Margolis H.S, Hepatitis C. Infect Dis Clin North Am., 1998; 12: 13-26.
4. Ralf B, Volker L, Replication of HCV, Journal of General Virology, 2000; 81:1631–1648.
5. Das D, Hong J, Chen S.H, Wang G, Beigelman L, Seiwert S.D, Buckman B.O, Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors. Bioorg Med Chem, 2011; 19: 4690-703.
6. Patil V.M, Gupta S.P, Samanta S, Masand N, Current perspective of HCV NS5B inhibitors: A review. Current Medicinal Chemistry, 2011, 18, 5564-97.
7. Zhao C, Wang Y, Ma S, Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors. Eur J Med Chem., 2015;102: 188-214.
8. Chinnaswamy S, Cai H, Kao C, An update on small molecule inhibitors of the HCV NS5B polymerase: effects on RNA synthesis in vitro and in cultured cells, and potential resistance in viral quasispecies, Virus Adaptation and Treatment, 2010; 2; 73–89.
9. Balavignesh, V.; Srinivasan, E.; Ramesh Babu, N.G.; Saravanan, N. Molecular Docking study on NS5B Polymerase of Hepatitis C virus by screening of volatile compounds from Acacia concina and ADMET prediction. 01, Int. J. of Pharm. & Life Sci. (IJPLS), 2013; 4: 2548-2558.
10. Srinivasan P, Sudha A, Shahul Hameed A, Prasanth K, Karthikeyan, M, Screening of medicinal plant compounds against NS5B polymerase of HCV (HCV) using molecular docking studies, Journal of Pharmacy Research, 2011;4: 136-140.
11. WHO, Hepatitis C. Incidence/Epidemiology under Section Surveillance and Control, 2002; Available online: (accessed, 10 October, 2017).
12. Shittu Lukeman. A. J, Bankole Munir A, Ahmed Titi, Aile Kingsley, Akinsanya,Mustapha A, Bankole, Marian N, Shittu Remilekun. K, Ashiru Oladapo A, Differential antimicrobial activity of the various crude leaves extracts of Sesame radiatum against some common pathogenic microorganisms. Sci. Res. Essay, 2006; 1:108-11.
13. Shitu Lukeman.A.J, Bankole M.A, Ahmed Titi, Bankole Marian N, Shittu Remilekun K, Saalu Chia L, Ashiru Oladapo A, Antibacterial and Antifungal Activities of Essential Oils of Crude Extracts of Sesame Radiatum against Some Common Pathogenic Micro-organisms. IJPT, 2007; 6: 165-170.
14. Shittu Lukeman.A. J, Shittu Remilekun K, Ogundipe Olufemi, Tayo O, Osunubi Abraham A A, Hypoglycaemia and improved testicular parameters in Sesamum radiatum treated normo-glycaemic adult male Sprague Dawley rats. African Journal of Biotechnology, 2009; 8: 2878-2886.
15. Shittu Lukeman A. J, Shittu Remilekun K. M, Improved Fertility Potential and Antimicrobial Activities of Sesame Leaves Phytochemicals. In: Rao, V. (Ed.).Phytochemicals as Nutraceuticals – Global Approaches to Their Role in Nutrition and Health. InTech, 2012; pp.67-88.
16. Bankole Munir A, Shittu Lukeman.A.J, Ahmed Titi. A, Bankole Marian N, Shittu,Remilekun. K, Ashiru Oladapo. A, Synergistic Antimicrobial Activities of Phytoestrogens In Crude Extracts Of Two Sesame Species Against Some Common Pathogenic Microorganism, Afr. J. Traditional, Complimentary Alternative Med., 2007; 4: 427-433.
17. Adlercreutz H, Fotsis T, Bannwart C, Wähälä K, Mäkelä T, Brunow G, Hase T, Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets, J. Steroid Biochem, 1986; 25: 791-7.
18. Shittu Lukeman. A. J, The effect of the aqueous crude leaves extract of Sesamum radiatum compared to Mesterolone (proviron) on the adult male Sprague Dawley rats testis and epididymis. MSc Dissertation. 2006, Lagos State University, College of Medicine, Ikeja, Nigeria.
19. Shittu Lukeman A. J, Reproductive Impact of Sesame Leaves Lignans in Adult Male SD Rats. LAP LAMBERT Academic AG & Co KG, 2010; ISBN: 978-3- 8383-8206-7, USA.
20. Murkies A, Phytoestrogens–what is the current knowledge? Aust. Fam. Physician, 1998; 27: S47-51.
21. Kuiper G.G.J.M, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors a and b. Endocrinology, 1997; 138: 863-70.
22. Lampe J.W, Atkinson C, Hullar M.A, Assessing exposure to lignans and their metabolites in humans, J AOAC Int., 2006; 89: 1174-81.
23. Ali A, Muhammad N. M, Chemical characterization and fatty acid profile of different sesame verities in Pakistan, Am. J. Sci. Ind. Res., 2013; 4: 540-545.
24. Rita De Cássia A.G, Macedo M.LR, Munhozi C.L, Wander Filiu L.H.V, Vanessa T.N, Hiane P.A, Sesame and flaxseed oil: nutritional quality and effects on serum lipids and glucose in rats, Food Sci. Technol, Campinas, 2013;33: 209-217.
25. Tyagi R, Sharma V, A comparison of volatile compounds in different genotypes of Sesamum indicum L. by GC-MS, Int J Pharm Sci Res, 2013; 5: 249-58.
26. Patil M, Neeta N. M, Kulkarni B, Comparative Qualitative Phytochemical analysis of Sesamum indicum L, Int.J.Curr. Microbiol. App. Sci Special Issue-, 2015; 2: 172-181.
27. Warra A.A, Jonathan B.L, Ibrahim B.D, Adedara A.O, GC- MS Analysis Of Hexane Extracts Of Two Varieties Of Sesame (Sesamun Indicum L.) Seed Oil, Int. J of Chemistry, Pharmacy & Technology, 2016; 1: 1-9.
28. Marwa A.M, Ashraf N, El-Sayed H, Amr N, ElGaleel K, Mohamed S.K, GC/MS Analyses of Avocado and Sesame Fixed Oils. Journal of Pharmacognosy and Phytochemistry, 2017; 6: 721-725.
29. Gill L.S, Ethnomedical uses of plants in Nigeria, Uniben Press, Edo State, Nigeria, 1992; p. 212.
30. Meng X.Y, Zhang H.X, Mezei M, Cui M, Molecular Docking: A Powerful Approach for Structure-Based Drug Discovery, Curr Comput Aided Drug Des, 2011; 7: 146-157.
31. Kai-Cheng H, Yen-Fu C, Shen-Rong L, Jinn-Moon Y, iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis, BMC Bioinformatics, 2011; 12: 1-11.
32. Van Lipzig M.M, ter Laak A.M, Jongejan A, Vermeulen N.P, Wamelink M, Geerke D, Meerman J.H, Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. J Med Chem, 2004; 47: 1018-30.
33. Shimoda M Shiratsuchi H, Nakada Y, Yin Wu, Osajinwa Y, Identification and sensory Characterization of volatile flavor compound in Sesame seed oil. J Agric Food Chem, 1996; 44: 3909–3912.
34. Stephen F, Altschul T.L, Madden A.A, Schäffer J.Z, Zheng Z, Webb M, David J. L, “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs”, Nucleic Acids Res., 1997; 25: 3389-3402.
35. Canales E, Carlson J.S, Appleby T, Fenaux M, Lee J, Tian Y, Tirunagari N, Wong M, Watkins W.J, Tri-substituted acylhydrazines as tertiary amide bioisosteres: HCV NS5B polymerase inhibitors, Bioorg Med Chem Lett., 2012; 22: 4288-92.
36. Roger S, Milner-White E.J, “RasMol: Biomolecular graphics for all”, Trends in Biochemical Sciences (TIBS), 1995; 20: p. 374
37. Dundas J, Zheng O, Jeffery T, Andrew B, Yaron T, Liang J, CASTp: computed atas of surface topography of proteins with structural and topographical mapping of functionally annotated residues, Nucl. Acids Res., 2006; 34: W116-W118.
38. Laskowski R.A, Hutchinson E.G, Michie A.D, Wallace A.C, Jones M.L, Thornton J.M, “PDBsum: a Web-based database of summaries and analyses of all PDB structures”, Trends in Biochemical Sciences, 1997; 22: 488–90.
39. Berman H.M, Westbrook J, Feng Z, Gilliland Z, Bhat T.N, Weissig H, Shindyalov I.N, Bourne P.E, The Protein Data Bank Nucleic Acids Research, 2000; 28: 235-242.
40. Pettersen E.F, Goddard T.D, Huang C.C, Couch G.S, Greenblatt D.M, Meng E.C, Ferrin T.E, UCSF Chimera–a visualization system for exploratory research and analysis, J Comput Chem. 20004; 25:1605-12.
41. Kai-Cheng H, Yen-Fu C, Jinn-Moon Y, GemAffinity: A Scoring Function for Predicting Binding Affinity and Virtual Screening, IEEE International Conference on Bioinformatics and Biomedicine, 2009; 24: 309-314.
42. Wang R, Fu Y, Lai L, A New Atom-Additive Method for Calculating Partition Coefficients, Journal of Chemical Information and Computer Sciences, 1997; 37: 615-621.
43. Lipinski C.A, Lombardo F, Dominy B.W, Feeney P.J, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev. 1997; 23: 3–25.
44. AdmetSAR @ LMMD. Available online: (accessed on 10 October, 2017).
45. Aditi G, Hirak J.C, Abhijit D, Protein Docking and Drug Design. Book chapter 9, pg 207-241. In: Applying Big Data Analytics in Bioinformatics and Medicine, 2018; pg 1-465. 182948?camid=4v1.
46. Aqvist J, Medina C, Samuelsson J. E, A new method for predicting binding affinity in computer-aided drug design, Protein Eng. 1994; 7: 385-391.
47. Kai-Cheng H, Yen-Fu C, Jinn-Moon Y, GemAffinity: A Scoring Function for Predicting Binding Affinity and Virtual Screening, IEEE International Conference on Bioinformatics and Biomedicine, 2009; 24: 309-314.
48. Jinn-Moon Y, Tsai-Wei S, A Pharmacophore-Based Evolutionary Approach for Screening Selective Estrogen Receptor Modulators, PROTEINS: Structure, Function, and Bioinformatics, 2005; 59: 205–220.
49. Punchavee S, Griangsak C, Volatile Compounds from “Som Poy” (Acacia concinna DC.), Quality, Efficacy, Safety, Processing & Trade in MAPs, Proc. WOCMAP III, 2005; 5:
50. Shen Y, Zhilun Z, Luyuan Z, Lingyan S, Sanjid Shahriar, Robin B, Chan G. P, Wei M, Metabolic activity induces membrane phase separation in endoplasmic reticulum, PNAS, 2017: 114: 13394-13399.
51. Leamy A.K, Robert A. E, Masakazu S, Pavlina T. I, David S. M, Alex H. B, Jamey D. Y, Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells. J Lipid Res, 2014:55: 1478–1488.
52. Quehenberger O, Aaron M, Armando A.H, Stephen B. M, David S. M, Alfred, H. M, Sibali B, Kristin N. J, Samuel K, Rebecca L. S, Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res, 2010; 51: 3299–3305.
53. Borradaile N.M, Xianlin H, Jeffrey D. H, Sarah E. G, Daniel S.O, Jean E. S, Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res, 2006; 47: 2726–2737.